EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Therapeutic Potential of Berberine in Lung Cancer

Zohreh Jafari, Shokouh Honarmand, Zeinab Abbasirad, Sahar Sadeghi, Ashkan Bigham iD

Archiv der Pharmazie · 2025-06 · 358 (6)

DOI: 10.1002/ardp.70013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 09.06.2025. Verfasst von Zohreh Jafari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Berberine, Lung Neoplasms, Antineoplastic Agents, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 201 Literaturangaben. Gefördert von: The authors received no specific funding for this study..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer has the second‐highest incidence rate after breast cancer and remains the leading cause of cancer‐related mortality. The 1‐year survival rate for lung cancer patients is below 50%, highlighting the urgent need for novel therapeutic strategies and drug development. Phytochemicals and their derivatives have been widely explored for their anticancer properties, serving as chemotherapeutic agents against various types of cancer. One of these herbal compounds, berberine (BBR), a quaternary isoquinoline alkaloid, has shown significant promise in preclinical studies and is currently undergoing clinical trials for cancer treatment. BBR exhibits diverse biological activities, contributing to its anticancer potential, including antioxidant, antidiarrheal, antidiabetic, antimicrobial, and so on. However, despite its multifunctional therapeutic potential, BBR faces several limitations, hindering its clinical application, like poor bioavailability, low tissue uptake, a short plasma half‐life, and rapid metabolic elimination. To address these challenges, various targeted drug delivery approaches have been developed to improve its efficacy. This review aims to provide a comprehensive overview of drug delivery strategies designed to encapsulate BBR for enhanced lung cancer therapy, highlighting the most recent advancements in the field. Moreover, the molecular structure of BBR and the biological pathways it targets to inhibit lung cancer progression are discussed in detail. Finally, BBR‐encapsulated nanocarriers specifically developed for lung cancer therapy are evaluated in terms of their benefits, limitations, and overall therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineLung NeoplasmsAntineoplastic AgentsAntineoplastic Agents, PhytogenicHumansAnimalsDrug Delivery SystemsBiological Availability

Stichwörter der Autor:innen

berberinebiological activitiesdrug deliverylung cancerpharmacokinetics

Substanzen

BerberineAntineoplastic AgentsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
  • Institute of Petroleum Engineering, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran.
  • Institute of Polymers, Composites and Biomaterials, National Research Council of Italy (IPCB-CNR), Naples, Italy.
  • Department of Chemical, Materials and Production Engineering, University of Naples Federico II, Naples, Italy.

ORCID-Profile: Ashkan Bigham

Förderung

  • The authors received no specific funding for this study.

Zitieren

APA

Jafari, Z., Honarmand, S., Abbasirad, Z., Sadeghi, S., & Bigham, A. (2025). The Therapeutic Potential of Berberine in Lung Cancer. Archiv der Pharmazie, 358(6). https://doi.org/10.1002/ardp.70013

Vancouver

Jafari Z, Honarmand S, Abbasirad Z, Sadeghi S, Bigham A. The Therapeutic Potential of Berberine in Lung Cancer. Archiv der Pharmazie. 2025;358(6). doi:10.1002/ardp.70013

BibTeX
@article{Jafari2025,
  author = {Jafari, Zohreh and Honarmand, Shokouh and Abbasirad, Zeinab and Sadeghi, Sahar and Bigham, Ashkan},
  title = {The Therapeutic Potential of Berberine in Lung Cancer},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {6},
  doi = {10.1002/ardp.70013}
}
Kostenlos starten →